title: Gelsolin amyloidosis as a cause of early aging and progressive bilateral facial paralysis.
abstract: BACKGROUND
  Gelsolin amyloidosis, or Meretoja disease, is a dominantly inherited syndrome in which the collection of amyloid leads to early aging, bilateral progressive facial paralysis, and corneal lattice dystrophy. Characteristically, the major symptoms appear in the fifth decade of life, with brow ptosis and blepharochalasis, drooping of the facial tissues, and oral disturbances. Indications and methods, as well as the results of plastic surgical treatment, seem varied. To better understand and operate on this challenging group of patients, the authors evaluated the surgical experience of their department.
  
  
  METHODS
  From the surgical database, all patients operated on in the authors' department for gelsolin amyloidosis from 1986 to 2004 were included. Disease severity was evaluated, together with data on the course of surgery, complications, and results.
  
  
  RESULTS
  During 1986 through 2004, 35 gelsolin amyloidosis patients underwent surgery, totaling 67 operations and 95 procedures; 89 percent consulted a plastic surgeon for brow ptosis or blepharochalasis, 15 percent for problems in oral function, and 21 percent for ocular dryness or corneal ulcers. Total bilateral forehead palsy was noted in 63 percent, total unilateral palsy in 14 percent, and weakness of the frontal branch in 23 percent. The buccal branch was affected in 40 percent. Postoperative complications were observed in 31 percent and minor complaints in 60 percent. Two-thirds, however, seemed satisfied with the results. The majority required reoperations.
  
  
  CONCLUSIONS
  Operative treatment of gelsolin amyloidosis is symptomatic. Due to relentless disease progression, a good functional and aesthetic result seems to require selected techniques and repeated surgery. Recognizing this underdiagnosed syndrome is essential.
authors: Helsinki, Finland From the Departments of Plastic Surgery and Neurology, Helsinki University Hospital.
authors: Tiia
authors: T
authors: Pihlamaa
authors: Jorma
authors: J
authors: Rautio
authors: Sari
authors: S
authors: Kiuru-Enari
authors: Sinikka
authors: S
authors: Suominen
references: Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms: A previously unrecognized heritable syndrome. Ann Clin Res. 1969;1:314–324.
references: Meretoja J. Tautiperintöämme: Suomalainen amyloiditauti (The Finnish amyloid disease representing our disease inheritage). J Finn Med Assoc. 1976;31:2234–2236.
references: Winkelman JE, Delleman JW, Ansink BJ. A hereditary syndrome consisting of peripheral polyneuropathy, skin changes and lattice-shaped corneal dystrophy. Klin Monatsbl Augenheilkd. 1971;159:618–623.
references: Boysen G, Galassi G, Kamieniecka Z, et al. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. J Neurol Neurosurg Psychiatry 1979;42:1020–1030.
references: Klaus E, Freyberger E, Kavka G, et al. Familial occurrence of a bulbar paralytic form of amyotropic lateral sclerosis with reticular corneal dystrophy and cutis hyperelastica in three sisters. Psychiatr Neurol (Basel) 1959;138:79–97.
references: Sack GH Jr, Dumars KW, Gummerson KS, et al. Three forms of dominant amyloid neuropathy. Johns Hopkins Med J. 1981;149:239–247.
references: Purcell JJ Jr, Rodrigues M, Chishti MI, et al. Lattice corneal dystrophy associated with familial systemic amyloidosis (Meretoja's syndrome). Ophthalmology 1983;90:1512–1517.
references: Starck T, Kenyon KR, Hanninen LA, et al. Clinical and histopathologic studies of two families with lattice corneal dystrophy and familial systemic amyloidosis (Meretoja syndrome). Ophthalmology 1991;98:1197–1206.
references: de la Chapelle A, Tolvanen R, Boysen G, et al. Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet. 1992;2:157–160.
references: Sunada Y, Shimizu T, Nakase H, et al. Inherited amyloid polyneuropathy type IV (gelsolin variant) in a Japanese family. Ann Neurol. 1993;33:57–62.
references: Yazaki M, Makishita H, Yazava M, et al. Clinicopathological study of type IV familial amyloid polyneuropathy in Japan. In: Kisilevsky R, Benson MD, Frangione B, et al. eds. Amyloid and Amyloidosis. New York: Parthenon Publishing; 1993:688–690.
references: Akiya S, Nishio Y, Ibi K, et al. Lattice corneal dystrophy type II associated with familial amyloid polyneuropathy type IV. Ophthalmology 1996;103:1106–1110.
references: Mearza AA, Ajao M, Etchells DE. Familial amyloidosis of the Finnish type. Br J Ophthalmol. 1999;83:1311.
references: Stewart HS, Parveen R, Ridgway AE, et al. Late onset lattice corneal dystrophy with systemic familial amyloidosis, amyloidosis V, in an English family. Br J Ophthalmol. 2000;84:390–394.
references: Conceicao I, Sales-Luis ML, De Carvalho M, et al. Gelsolin-related familial amyloidosis, Finnish type, in a Portuguese family: Clinical and neurophysiological studies. Muscle Nerve 2003;28:715–721.
references: Chastan N, Baert-Desurmont S, Saugier-Veber P, et al. Cardiac conduction alterations in a French family with amyloidosis of the Finnish type with the p.Asp187Tyr mutation in the GSN gene. Muscle Nerve 2006;33:113–119.
references: Contegal F, Bidot S, Thauvin C, et al. Finnish amyloid polyneuropathy in a French patient. Rev Neurol (Paris). 2006;162:997–1001.
references: Ardalan MR, Shoja MM, Kiuru-Enari S. Amyloidosis-related nephrotic syndrome due to a G654A gelsolin mutation: The first report from the Middle East. Nephrol Dial Transplant. 2007;22:272–275.
references: Huerva V, Velasco A, Sanchez MC, et al. Lattice corneal dystrophy type II: Clinical, pathologic, and molecular study in a Spanish family. Eur J Ophthalmol. 2007;17:424–429.
references: Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid 1998;5:55–66.
references: Paunio T, Kiuru S, Hongell V, et al. Solid-phase minisequencing test reveals Asp187—asn (G654—A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis. Genomics 1992;13:237–239.
references: Juusela P, Tanskanen M, Nieminen A, et al. Hereditary gelsolin amyloidosis mimicking Sjogren's syndrome. Clin Rheumatol. 2009;28:1351–1354.
references: Kiuru S. Familial amyloidosis of the Finnish type (FAF): A clinical study of 30 patients. Acta Neurol Scand. 1992;86:346–353.
references: Meretoja J, Jokinen EJ, Collan Y, et al. Renal biopsy findings in familial amyloidosis with corneal lattice dystrophy: An immuno-histochemical, light-microscopical and electron-microscopical study. Acta Pathol Microbiol Scand Suppl. 1972;233:228–238.
references: Kiuru S, Matikainen E, Kupari M, et al. Autonomic nervous system and cardiac involvement in familial amyloidosis, Finnish type (FAF). J Neurol Sci. 1994;126:40–48.
references: Meretoja J. Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy. Clin Genet. 1973;4:173–185.
references: Maury CP, Kere J, Tolvanen R, et al. Homozygosity for the Asn187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics 1992;13:902–903.
references: Witke W, Sharpe AH, Hartwig JH, et al. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell 1995;81:41–51.
references: Goncalves AF, Dias NG, Moransard M, et al. Gelsolin is required for macrophage recruitment during remyelination of the peripheral nervous system. Glia 2010;58:706–715.
references: Levy E, Haltia M, Fernandez-Madrid I, et al. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med. 1990;172:1865–1867.
references: Maury CP, Kere J, Tolvanen R, et al. Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett. 1990;276:75–77.
references: de la Chapelle A, Kere J, Sack GH Jr, et al. Familial amyloidosis, Finnish type: G654—A mutation of the gelsolin gene in Finnish families and an unrelated American family. Genomics 1992;13:898–901.
references: Meretoja J, Teppo L. Histopathological findings of familial amyloidosis with cranial neuropathy as principal manifestation: Report on three cases. Acta Pathol Microbiol Scand A 1971;79:432–440.
references: Haltia M, Ghiso J, Prelli F, et al. Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol. 1990;136:1223–1228.
references: Kiuru-Enari S, Keski-Oja J, Haltia M. Cutis laxa in hereditary gelsolin amyloidosis. Br J Dermatol. 2005;152:250–257.
references: Kiuru-Enari S, Somer H, Seppalainen AM, et al. Neuromuscular pathology in hereditary gelsolin amyloidosis. J Neuropathol Exp Neurol. 2002;61:565–571.
references: Kiuru S, Salonen O, Haltia M. Gelsolin-related spinal and cerebral amyloid angiopathy. Ann Neurol. 1999;45: 305–311.
references: Kiuru S, Seppalainen AM. Neuropathy in familial amyloidosis, Finnish type (FAF): Electrophysiological studies. Muscle Nerve 1994;17:299–304.
references: Kazmirski SL, Howard MJ, Isaacson RL, et al. Elucidating the mechanism of familial amyloidosis–Finnish type: NMR studies of human gelsolin domain 2. Proc Natl Acad Sci USA. 2000;97:10706–10711.
references: Robinson RC, Choe S, Burtnick LD. The disintegration of a molecule: The role of gelsolin in FAF, familial amyloidosis (Finnish type). Proc Natl Acad Sci USA. 2001;98:2117–2118.
references: Westberg JA, Zhang KZ, Andersson LC. Regulation of neural differentiation by normal and mutant (G654A, amyloidogenic) gelsolin. FASEB J. 1999;13:1621–1626.
references: Rintala AE, Alanko A, Mäkinen J, et al. Primary hereditary systemic amyloidosis (Meretoja's syndrome): Clinical features and treatment by plastic surgery. Scand J Plast Reconstr Surg Hand Surg. 1988;22:141–145.